Use of 3,11b-cis-dihydrotetrabenazine for the treatment of symptoms of Huntington's disease

摘要

The invention provides 3,11b- cis -dihydrotetrabenazine for use in halting or slowing the progress of one or more symptoms of Huntington's disease in a patient, and more particularly a symptom selected from involuntary movements such as involuntary chorea, tremors and twitches, and degeneration in gait.